
Patients with advanced malignancy may develop nausea and vomiting from causes unrelated to the cancer e.g. gall bladder disease or gastroenteritis. 1  Table 27 .1 lists some common causes of nausea and vomiting in patients with advanced cancer.
1, 2 Gastric outlet obstruction Vestibular disturbance  Anti-emetics are neurotransmitter-blocking agents and are effective at different receptor sites (see Figure 27 .1). 3
The choice of anti-emetic will be influenced by the cause of vomiting. They may be administered by a variety of routes. The oral or subcutaneous routes are the preferred options in palliative care. 4 10mg-20mg tds-qds.
GUIDELINES


n/a n/a Can be given via rectal route. Does not cross the blood-brain barrier so less likely to give extrapyramidal reactions compared to haloperidol.
Haloperidol Butyrophenone
Chemical causes e.g. opioids.
Metabolic causes.
1.5mg-5mg nocte.
(maximum10 mg daily)
1.5mg-5mg
(maximum 10mg daily) NB: Subcutaneous: oral potency of haloperidol is 2:1.
1.5mg-3mg subcutaneously as required.
Risk of extrapyramidal symptoms. Single daily dose usually sufficient because of long half life. Parental administration is more potent therefore consider starting at a lower dose. 
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